October 28, 2015
Yakult Honsha and Nissan Chemical Industries have entered into a license agreement to codevelop a novel platelet increasing agent NIP-022 (development code) in Japan, the companies said on October 27. With the deal, Yakult will receive exclusive rights from Nissan...read more